Article Details
Retrieved on: 2019-12-16 03:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>SAN DIEGO, Dec. 16, 2019 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here